OPHTHALMIC THERAPEUTIC COMPOSITION

摘要

It is intended to find out the minimum activity expression site of fibronectin, clarify the function of the minimum unit in the ophthalmic field and provide an ophthalmic therapeutic composition containing the same as the active ingredient. Namely, an ophthalmic therapeutic composition, in particular, a remedy for corneal injury which contains as the active ingredient a peptide PHSRN (Pro-His-Ser-Arg-Asn), its derivative Ac-Pro-His-Ser-Arg-Asn-NH2 or a pharmaceutically acceptable salt thereof. A preferred dosage form of the composition is an ophthalmic solution.